Ubrelvy on SilverScript Choice (S5601-028)
ubrogepant
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 16 per 30 days.
$330.63
Patient pays / month, after deductible
$834.93
Patient pays / month, before the $615.00 deductible
$991.90
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
UBRELVY 100 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $1,836.86 for a month. Other covered strengths are listed below.
Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| UBRELVY 50 mg Tablet | 3 | $330.66 | PA · 16 per 30 days |
| UBRELVY 100 mg Tablet | 3 | $330.63 | PA · 16 per 30 days |
Other CGRP migraine drugs on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-028